Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

NCT00616772 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

682

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease
Coronary Heart Disease
Dyslipidemia

Interventions

DRUG: ABT-335
DRUG: Placebo
OTHER: Atorvastatin

Sponsor

AbbVie (prior sponsor, Abbott)